drugset / Trial / NCT02407782

Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults

NCT02407782

Phase 3 Completed 1092 enrolled University Hospital, Bordeaux
RandomizedParallel-groupSingle-blindTreatment

Summary

Scabies remains a frequent condition that affects adults and children. The aim of this study is to compare the efficacy and safety of two drug treatments against scabies in children and their close contacts. One group will apply topical permethrin 5% and the other group will receive oral ivermectin. Both groups will be treated twice, once at inclusion and the second time 10 days later. Both treatment regimens have been used widely and are safe to use.

Timeline

Start
2016-01-19
Primary completion
2021-12-16
Completion
2022-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule 200 ug/kg Oral
Subject Permethrin Small molecule 5 % Topical

Indications